AMEX · EGG

Enigmatig Limited

$2.05 -$3.05 (-59.80%) 1D Pre-market
Session Pulse Pre-market 2 mentions on Wed · 2 bullish / 0 bearish tags No new SEC filings since Mon close Full pulse →

Key Metrics

$142.01M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow −$1.96M
Beta · 1Y 0.35
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    From its Jun 4 high, the share price fell 81%.

    Peak close $10.85 on Jun 4; trough close $2.05 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -81%
  • Jul 27
    The stock moved -59.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 27
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 5
    The stock moved -48.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 5

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$142.01M
Enterprise value
Shares outstanding27.8M
52-wk range$2.05 – $13.07
Avg volume · 20D109.0K
Net cash
Book value / share$0.57
ExchangeAMEX
About Enigmatig Limited
IPO dateJun 18, 2025
Employees17

Enigmatig Ltd is an international consultancy firm providing one-stop cross-border licensing solutions and related services.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio8.31
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$13.28M

Cash Flow · TTM

Operating CF −$1.72M
Capex −$246.11K
Free cash flow −$1.96M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

Needs two fiscal years of filings

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-09-30 · computed by TickerWolf from SEC filings